Remote Monitoring in Automated Peritoneal Dialysis Improves Treatment Adherence and Reduces Hospitalization Burden: A Prospective Multicenter Cohort Study.

IF 1.9 Q3 HEALTH CARE SCIENCES & SERVICES
Telemedicine reports Pub Date : 2026-09-10 eCollection Date: 2026-01-01 DOI:10.1177/26924366261483461
Ji Eun Kim, Myung Gyu Kim, Jin Joo Cha, Eun Jung Cho, Young Joo Kwon, Gang-Jee Ko
{"title":"Remote Monitoring in Automated Peritoneal Dialysis Improves Treatment Adherence and Reduces Hospitalization Burden: A Prospective Multicenter Cohort Study.","authors":"Ji Eun Kim, Myung Gyu Kim, Jin Joo Cha, Eun Jung Cho, Young Joo Kwon, Gang-Jee Ko","doi":"10.1177/26924366261483461","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Remote patient monitoring (RPM) in peritoneal dialysis (PD) has the potential to improve adherence and clinical outcomes, yet comparative real-world data among PD modalities are limited. This study aimed to compare PD treatment adherence, hospitalization burden, fluid status, and health care costs among patients undergoing continuous ambulatory PD (CAPD), automated PD (APD), and remote monitoring-assisted APD (RM-APD).</p><p><strong>Methods: </strong>In this prospective multicenter cohort study, 73 patients maintained on a single PD modality for ≥1 year were enrolled (CAPD: <i>n</i> = 26; APD: <i>n</i> = 23; RM-APD: <i>n</i> = 24). Treatment adherence was defined as the proportion of prescribed PD treatments actually performed (sessions for APD/RM-APD; exchanges for CAPD), expressed on a per-treatment-day basis derived from each patient's prescription and dialysate supply records. In RM-APD patients, supply-based estimates were cross-validated against Sharesource treatment records. Fluid status was evaluated using the overhydration-to-extracellular water ratio (OH/ECW%). Hospitalization days, emergency department visits, health care costs, and clinical parameters were assessed over 1 year.</p><p><strong>Results: </strong>The RM-APD group showed the highest treatment adherence (median 83.4%, interquartile range 81.0-88.2), compared with 81.0% in CAPD and 78.4% in APD (Kruskal-Wallis <i>p</i> = 0.010). Adjusted analysis confirmed superior adherence in RM-APD compared with APD (<i>p</i> = 0.013) and CAPD (<i>p</i> = 0.041). In a subset of RM-APD patients, the supply-based estimate correlated well with Sharesource-recorded treatment delivery. RM-APD patients had significantly fewer hospitalization days (adjusted incidence rate ratio 0.34; 95% confidence interval 0.23-0.49; <i>p</i> < 0.001) and lower inpatient costs than APD (<i>p</i> = 0.037). OH/ECW% reduction was greater in RM-APD than CAPD (<i>p</i> = 0.042), while nutritional markers, dialysis adequacy (Kt/V), and ejection fraction were comparable across groups.</p><p><strong>Conclusions: </strong>Integration of remote monitoring into APD was associated with improved adherence, reduced hospitalization burden, and better volume control compared with conventional PD modalities. These findings provide real-world evidence that RPM-enabled home dialysis can enhance both clinical outcomes and health care efficiency, supporting broader implementation of telehealth-based care models for patients with end-stage kidney disease.</p>","PeriodicalId":94218,"journal":{"name":"Telemedicine reports","volume":"7 ","pages":"26924366261483461"},"PeriodicalIF":1.9000,"publicationDate":"2026-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13562868/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Telemedicine reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/26924366261483461","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Remote patient monitoring (RPM) in peritoneal dialysis (PD) has the potential to improve adherence and clinical outcomes, yet comparative real-world data among PD modalities are limited. This study aimed to compare PD treatment adherence, hospitalization burden, fluid status, and health care costs among patients undergoing continuous ambulatory PD (CAPD), automated PD (APD), and remote monitoring-assisted APD (RM-APD).

Methods: In this prospective multicenter cohort study, 73 patients maintained on a single PD modality for ≥1 year were enrolled (CAPD: n = 26; APD: n = 23; RM-APD: n = 24). Treatment adherence was defined as the proportion of prescribed PD treatments actually performed (sessions for APD/RM-APD; exchanges for CAPD), expressed on a per-treatment-day basis derived from each patient's prescription and dialysate supply records. In RM-APD patients, supply-based estimates were cross-validated against Sharesource treatment records. Fluid status was evaluated using the overhydration-to-extracellular water ratio (OH/ECW%). Hospitalization days, emergency department visits, health care costs, and clinical parameters were assessed over 1 year.

Results: The RM-APD group showed the highest treatment adherence (median 83.4%, interquartile range 81.0-88.2), compared with 81.0% in CAPD and 78.4% in APD (Kruskal-Wallis p = 0.010). Adjusted analysis confirmed superior adherence in RM-APD compared with APD (p = 0.013) and CAPD (p = 0.041). In a subset of RM-APD patients, the supply-based estimate correlated well with Sharesource-recorded treatment delivery. RM-APD patients had significantly fewer hospitalization days (adjusted incidence rate ratio 0.34; 95% confidence interval 0.23-0.49; p < 0.001) and lower inpatient costs than APD (p = 0.037). OH/ECW% reduction was greater in RM-APD than CAPD (p = 0.042), while nutritional markers, dialysis adequacy (Kt/V), and ejection fraction were comparable across groups.

Conclusions: Integration of remote monitoring into APD was associated with improved adherence, reduced hospitalization burden, and better volume control compared with conventional PD modalities. These findings provide real-world evidence that RPM-enabled home dialysis can enhance both clinical outcomes and health care efficiency, supporting broader implementation of telehealth-based care models for patients with end-stage kidney disease.

远程监测自动腹膜透析提高治疗依从性,减少住院负担:一项前瞻性多中心队列研究
腹膜透析(PD)中的远程患者监测(RPM)有可能改善依从性和临床结果,但PD模式之间的比较现实数据有限。本研究旨在比较连续门诊PD (CAPD)、自动PD (APD)和远程监测辅助APD (RM-APD)患者的PD治疗依从性、住院负担、体液状态和医疗费用。方法:在这项前瞻性多中心队列研究中,纳入73例维持单一PD模式≥1年的患者(CAPD: n = 26; APD: n = 23; RM-APD: n = 24)。治疗依从性定义为实际执行的PD处方治疗的比例(APD/RM-APD的疗程;CAPD的交换次数),以每个治疗日为基础表示,来源于每个患者的处方和透析液供应记录。在RM-APD患者中,基于供应的估计与Sharesource治疗记录交叉验证。使用过水合与细胞外水比(OH/ECW%)评估流体状态。住院天数、急诊科就诊次数、医疗费用和临床参数在1年内进行评估。结果:RM-APD组治疗依从性最高(中位数83.4%,四分位数间距81.0-88.2),而CAPD组为81.0%,APD组为78.4% (Kruskal-Wallis p = 0.010)。调整分析证实RM-APD的依从性优于APD (p = 0.013)和CAPD (p = 0.041)。在一部分RM-APD患者中,基于供应的估计与sharesource记录的治疗交付有很好的相关性。RM-APD患者住院天数显著少于APD患者(调整后发病率比0.34;95%可信区间0.23-0.49;p < 0.001),住院费用显著低于APD患者(p = 0.037)。rh - apd患者的OH/ECW%降低率高于CAPD患者(p = 0.042),而营养指标、透析充分性(Kt/V)和射血分数在各组间具有可比性。结论:与传统PD模式相比,将远程监测整合到APD中可以提高依从性,减轻住院负担,并更好地控制体积。这些发现提供了现实世界的证据,证明rpm支持的家庭透析可以提高临床结果和医疗效率,支持对终末期肾病患者更广泛地实施基于远程医疗的护理模式。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.80
自引率
0.00%
发文量
0
审稿时长
8 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书